GHK-Cu has the larger published research base over 100 published studies spanning five decades
This increase reflects a pattern of growing use of newer GLP-1s, such as Ozempic and Mounjaro, while use of older products, such as Byetta (approved in 2005), Victoza (approved in 2010), and Trulicity (approved in 2014), has declined
PBM, involving the application of red and/or near-infrared (NIR) light to the brain transcranially or intranasally, has shown the potential to expedite recovery from TBI symptoms and mitigate associated symptoms
Sp was able to restore cellular redox homeostasis under induced oxidative stress in mammalian cells and in vivo model, Drosophila where it ameliorated catalase and glutathione peroxidase deficiency
The rise of these distinct but powerful medication classes gives us more options than ever before
This incentivized higher patient turnover, increased testing, and upselling services